Actively Recruiting
HER2-positive Breast Cancer Registry
Led by Priyanka Sharma · Updated on 2025-09-10
1000
Participants Needed
6
Research Sites
1044 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this observational study is to better understand links between patient or tumor characteristics and outcomes in HER2-positive breast cancer.
CONDITIONS
Official Title
HER2-positive Breast Cancer Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of stage I to IV HER2-positive breast cancer
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 6 locations
1
KUCC - Indian Creek
Overland Park, Kansas, United States, 66211
Active, Not Recruiting
2
KUCC - Overland Park
Overland Park, Kansas, United States, 66215
Active, Not Recruiting
3
KUCC - Briarcliff
Westwood, Kansas, United States, 66205
Active, Not Recruiting
4
KUCC - Olathe
Westwood, Kansas, United States, 66205
Active, Not Recruiting
5
The University of Kansas Cancer Center
Westwood, Kansas, United States, 66205
Actively Recruiting
6
KUCC - Lee's Summit
Lee's Summit, Missouri, United States, 64064
Active, Not Recruiting
Research Team
S
Study Coordinator
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here